scorecardresearch
Thursday, September 4, 2025
TopicMankind Pharma

Topic: Mankind Pharma

Income tax dept searches Mankind Pharma’s office in Delhi, CNBC TV18 reports

Chris Thomas -
The company's shares fell as much as 5.5% on the news, which comes days after the condom maker listed on exchanges with sharp gains.

Mankind Pharma eyes $5 billion valuation in IPO

Rama Venkat -
The IPO for the company will consist of nearly 40.1 million shares on offer for sale from existing shareholders, according to a prospectus.

Mankind Pharma receives DRDO license to manufacture, market Covid drug 2-DG

PTI -
Drugs Controller General of India (DCGI) had permitted the emergency use of 2-DG on 1 May, as an adjunct treatment for moderate to severe Covid-19 patients.

On Camera

YourTurn

Opinion

Counter-insurgency is Indian military’s reality. Op Sindoor was brief flash in combat spectrum

Manvendra Singh -
The Chief of Defence Staff was spot on when he declared war fighting as ‘military’s bread and butter.’

Superman Modi to superpower meeting — Indian TV anchors script a Tianjin blockbuster

Why India should let the rupee fall

Economy

GST 2.0: India streamlines indirect tax regime amid Trump tariffs & what it means for consumers

Sampurna Panigrahi -
Goods and Services Tax Council paves way for a broad two-slab structure of 5% and 18% with a demerit rate of 40% for super luxury and 'sin' goods.

Defence

Choppy ride for India’s submarine ambition: Project P-751 chugs forward, Scorpenes a stinging tale

Snehesh Alex Philip -
With P75I still years away & the follow-on Scorpenes stuck, India’s long-promised 30-yr submarine plan remains behind schedule

National Interest

For Indian Mercedes, Asim Munir’s dumper truck in mirror is closer than it appears

Shekhar Gupta -
From Munir’s point of view, a few bumps here and there is par for the course. He isn’t going to drive his dumper truck to its doom. He wants to use it as a weapon.

Follow us

Copyright © 2025 Printline Media Pvt. Ltd. All rights reserved.